First in-human study of golodirsen for Duchenne muscular dystrophy shows safety and biologic activity
This first-in-human study of golodirsen showed its long-term safety and biologic activity in patients with Duchenne Muscular Dystrophy (DMD). The approved exon-skipping therapy is designed to enable the production of functional ...
Nov 30, 2021
0
0